Halper Sadeh Launches Probes into Three Corporate Transactions

The scrutiny centers on three distinct transactions where terms may prevent superior offers from emerging or unfairly benefit company insiders. Priority Technology Holdings faces investigation over its sale to an investor group led by CEO Thomas Priore for $8.05 per share. Similarly, the $20.35 per share cash acquisition of MISTRAS Group by affiliates of H.I.G. Capital is under review. For Aethlon Medical, the concern lies in its merger with North Immunology, which would leave existing Aethlon shareholders with only 4.75% of the combined entity.

Halper Sadeh intends to seek increased compensation or additional disclosures for affected investors. The firm, based in New York, operates on a contingent fee basis for these matters, asserting that standard shareholders often lose out when management-led transactions move forward without adequate transparency. These investigations follow a pattern of litigation aimed at corporate governance reform, though the firm notes that previous legal outcomes do not guarantee future results.